These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 9406236

  • 1. Selenium and the thioredoxin redox system: effects on cell growth and death.
    Powis G, Gasdaska JR, Gasdaska PY, Berggren M, Kirkpatrick DL, Engman L, Cotgreave IA, Angulo M, Baker A.
    Oncol Res; 1997; 9(6-7):303-12. PubMed ID: 9406236
    [Abstract] [Full Text] [Related]

  • 2. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
    Engman L, Cotgreave I, Angulo M, Taylor CW, Paine-Murrieta GD, Powis G.
    Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
    Gallegos A, Berggren M, Gasdaska JR, Powis G.
    Cancer Res; 1997 Nov 01; 57(21):4965-70. PubMed ID: 9354464
    [Abstract] [Full Text] [Related]

  • 4. Cellular thioredoxin reductase activity is regulated by selenium.
    Berggren M, Gallegos A, Gasdaska J, Powis G.
    Anticancer Res; 1997 Nov 01; 17(5A):3377-80. PubMed ID: 9413175
    [Abstract] [Full Text] [Related]

  • 5. The thioredoxin/thioredoxin reductase redox system and control of cell growth.
    Powis G, Oblong JE, Gasdaska PY, Berggren M, Hill SR, Kirkpatrick DL.
    Oncol Res; 1994 Nov 01; 6(10-11):539-44. PubMed ID: 7620223
    [Abstract] [Full Text] [Related]

  • 6. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism.
    Gasdaska JR, Berggren M, Powis G.
    Cell Growth Differ; 1995 Dec 01; 6(12):1643-50. PubMed ID: 9019170
    [Abstract] [Full Text] [Related]

  • 7. A redox-inactive thioredoxin reduces growth and enhances apoptosis in WEHI7.2 cells.
    Freemerman AJ, Powis G.
    Biochem Biophys Res Commun; 2000 Jul 21; 274(1):136-41. PubMed ID: 10903908
    [Abstract] [Full Text] [Related]

  • 8. Thioredoxin redox control of cell growth and death and the effects of inhibitors.
    Powis G, Kirkpatrick DL, Angulo M, Baker A.
    Chem Biol Interact; 1998 Apr 24; 111-112():23-34. PubMed ID: 9679540
    [Abstract] [Full Text] [Related]

  • 9. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.
    Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, Powis G.
    Anticancer Res; 1996 Apr 24; 16(6B):3459-66. PubMed ID: 9042207
    [Abstract] [Full Text] [Related]

  • 10. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells.
    Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaska PY, Berggren M, Briehl MM, Powis G.
    Cancer Res; 1996 Dec 15; 56(24):5765-70. PubMed ID: 8971189
    [Abstract] [Full Text] [Related]

  • 11. Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system.
    Jönsson-Videsäter K, Björkhem-Bergman L, Hossain A, Söderberg A, Eriksson LC, Paul C, Rosén A, Björnstedt M.
    Biochem Pharmacol; 2004 Feb 01; 67(3):513-22. PubMed ID: 15037203
    [Abstract] [Full Text] [Related]

  • 12. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo.
    Baker A, Payne CM, Briehl MM, Powis G.
    Cancer Res; 1997 Nov 15; 57(22):5162-7. PubMed ID: 9371519
    [Abstract] [Full Text] [Related]

  • 13. Calcium-dependent oxidation of thioredoxin during cellular growth initiation.
    Gitler C, Zarmi B, Kalef E, Meller R, Zor U, Goldman R.
    Biochem Biophys Res Commun; 2002 Jan 18; 290(2):624-8. PubMed ID: 11785944
    [Abstract] [Full Text] [Related]

  • 14. Redox active disulfides: the thioredoxin system as a drug target.
    Kirkpatrick DL, Ehrmantraut G, Stettner S, Kunkel M, Powis G.
    Oncol Res; 1997 Jan 18; 9(6-7):351-6. PubMed ID: 9406241
    [Abstract] [Full Text] [Related]

  • 15. Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.
    Hu J, Ma X, Lindner DJ, Karra S, Hofmann ER, Reddy SP, Kalvakolanu DV.
    Oncogene; 2001 Jul 12; 20(31):4235-48. PubMed ID: 11464290
    [Abstract] [Full Text] [Related]

  • 16. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation.
    Karimpour S, Lou J, Lin LL, Rene LM, Lagunas L, Ma X, Karra S, Bradbury CM, Markovina S, Goswami PC, Spitz DR, Hirota K, Kalvakolanu DV, Yodoi J, Gius D.
    Oncogene; 2002 Sep 12; 21(41):6317-27. PubMed ID: 12214272
    [Abstract] [Full Text] [Related]

  • 17. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase.
    Ganther HE.
    Carcinogenesis; 1999 Sep 12; 20(9):1657-66. PubMed ID: 10469608
    [Abstract] [Full Text] [Related]

  • 18. Thioredoxin and thioredoxin reductase: current research with special reference to human disease.
    Holmgren A, Lu J.
    Biochem Biophys Res Commun; 2010 May 21; 396(1):120-4. PubMed ID: 20494123
    [Abstract] [Full Text] [Related]

  • 19. Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity.
    Lee SR, Bar-Noy S, Kwon J, Levine RL, Stadtman TC, Rhee SG.
    Proc Natl Acad Sci U S A; 2000 Mar 14; 97(6):2521-6. PubMed ID: 10688911
    [Abstract] [Full Text] [Related]

  • 20. Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs.
    Kunkel MW, Kirkpatrick DL, Johnson JI, Powis G.
    Anticancer Drug Des; 1997 Dec 14; 12(8):659-70. PubMed ID: 9448705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.